glycerol has been researched along with Meningitis, Pneumococcal in 4 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
| Excerpt | Relevance | Reference |
|---|---|---|
| "With bacterial meningitis, the child's presenting status and young age are the most important predictors of hearing impairment." | 2.75 | Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. ( Arbo, A; Bologna, R; Dourado de Andrade, S; Fernández, J; Gonzalez Ayala, S; González Mata, A; Goyo, J; Jauhiainen, T; López, E; Miño, G; Peltola, H; Roine, I; Sarna, S; Zavala, I, 2010) |
| "In animal models of Streptococcus pneumoniae meningitis, rifampin is neuroprotective in comparison to ceftriaxone." | 1.32 | Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. ( Böttcher, T; Bunkowski, S; Christen, S; Gerber, J; Goiny, M; Kuhnt, U; Lotz, M; Lykkesfeldt, J; Nau, R; Ren, H; Schau, I; Spreer, A; Werner, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singhi, S | 1 |
| Järvinen, A | 1 |
| Peltola, H | 3 |
| Roine, I | 1 |
| Fernández, J | 1 |
| González Mata, A | 1 |
| Zavala, I | 1 |
| Gonzalez Ayala, S | 1 |
| Arbo, A | 1 |
| Bologna, R | 1 |
| Goyo, J | 1 |
| López, E | 1 |
| Miño, G | 1 |
| Dourado de Andrade, S | 1 |
| Sarna, S | 1 |
| Jauhiainen, T | 1 |
| Blaser, C | 1 |
| Klein, M | 1 |
| Grandgirard, D | 1 |
| Wittwer, M | 1 |
| Weigand, M | 1 |
| Koedel, U | 1 |
| Leib, SL | 1 |
| Böttcher, T | 1 |
| Ren, H | 1 |
| Goiny, M | 1 |
| Gerber, J | 1 |
| Lykkesfeldt, J | 1 |
| Kuhnt, U | 1 |
| Lotz, M | 1 |
| Bunkowski, S | 1 |
| Werner, C | 1 |
| Schau, I | 1 |
| Spreer, A | 1 |
| Christen, S | 1 |
| Nau, R | 1 |
2 trials available for glycerol and Meningitis, Pneumococcal
| Article | Year |
|---|---|
Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis.
Topics: Ceftriaxone; Cerebrovascular Circulation; Child; Child, Preschool; Dexamethasone; Double-Blind Metho | 2008 |
Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol.
Topics: Administration, Oral; Adolescent; Audiometry; Ceftriaxone; Child; Child, Preschool; Confidence Inter | 2010 |
2 other studies available for glycerol and Meningitis, Pneumococcal
| Article | Year |
|---|---|
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Enzyme Inhibitors; Glycerol; Humans; Matrix Metalloprot | 2010 |
Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Brain; Ceftriaxone; Cell Line, Tumor; Cerebrospina | 2004 |